Department of Nutritional Medicine, University of Hohenheim, Fruwirthstraße 12, 70599 Stuttgart, Germany.
Cytokine. 2012 May;58(2):178-85. doi: 10.1016/j.cyto.2012.01.001. Epub 2012 Feb 1.
Mast cells are key effector cells of immediate type allergic reactions. Upon activation they release a broad array of pre-stored and de novo synthesized mediators including immunoregulatory cytokines and chemokines. Here, we analyzed the chemokine profile expressed by mature human mast cells. Human mast cells were isolated from intestinal tissue and cultured with stem cell factor (SCF) in the presence or absence of IL-4 for 10d. Cells were stimulated by cross-linking of the high affinity IgE receptor (FcεRI) and/or by SCF. Chemokine and chemokine receptor mRNA expression was determined by real-time RT-PCR and chemokine release was measured by multiplex bead immunoassay. Out of 43 chemokines and 19 chemokine receptors human intestinal mast cells express 27 chemokines and nine chemokine receptors. Twelve chemokines (CCL1, CCL2, CCL3, CCL4, CCL5, CCL7, CCL18, CCL20, CXCL2, CXCL3, CXCL8, and XCL1) were more than four-fold up-regulated in response to FcεRI cross-linking. Combination of pre-culture with IL-4 and/or stimulation with SCF in addition to FcεRI cross-linking further increased the antigen-dependent expression of mRNA for most chemokines. In contrast, the expression of CCL20, CXCL2, and CXCL3 was strongly inhibited by IL-4 treatment. In conclusion, human intestinal mast cells express a broad spectrum of different chemokines underlining their important role as immunoregulatory cells. Furthermore, combined treatment with IL-4 and SCF increases the antigen-mediated expression and release of multiple chemokines, but IL-4 priming inhibits the expression of CCL20, CXCL2, and CXCL3.
肥大细胞是速发型过敏反应的关键效应细胞。活化后,它们释放广泛的预存和新合成的介质,包括免疫调节细胞因子和趋化因子。在这里,我们分析了成熟人肥大细胞表达的趋化因子谱。人肥大细胞从肠组织中分离出来,并在干细胞因子 (SCF) 的存在或不存在下培养 10 天,用高亲和力 IgE 受体 (FcεRI) 交联和/或 SCF 刺激细胞。通过实时 RT-PCR 测定趋化因子和趋化因子受体 mRNA 的表达,通过多重珠免疫测定法测量趋化因子的释放。在 43 种趋化因子和 19 种趋化因子受体中,人肠肥大细胞表达 27 种趋化因子和 9 种趋化因子受体。12 种趋化因子(CCL1、CCL2、CCL3、CCL4、CCL5、CCL7、CCL18、CCL20、CXCL2、CXCL3、CXCL8 和 XCL1)在 FcεRI 交联后上调超过 4 倍。在 FcεRI 交联的基础上,预培养与 IL-4 和/或 SCF 刺激相结合,进一步增加了大多数趋化因子的抗原依赖性表达。相比之下,CCL20、CXCL2 和 CXCL3 的表达被 IL-4 处理强烈抑制。总之,人肠肥大细胞表达广泛的不同趋化因子,强调了它们作为免疫调节细胞的重要作用。此外,IL-4 和 SCF 的联合治疗增加了抗原介导的多种趋化因子的表达和释放,但 IL-4 启动抑制了 CCL20、CXCL2 和 CXCL3 的表达。